Veronica Ndegwa-Gibbons
Psychiatric/Mental Health · Suwanee, GANPI 1487897112
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 285 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 285 payments — averaging $18.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- AbbVie$1K
- Johnson & Johnson$713
- Alkermes, Inc.$592
- Lundbeck LLC$279
- Axsome Therapeutics, Inc.$230
- plus $1K from 15 others
What the payments were for
- Food & beverage$5,35199%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 44 | $1,150 |
| AbbVie | 83 | $1,040 |
| Johnson & Johnson | 27 | $713 |
| Alkermes, Inc. | 29 | $592 |
| Lundbeck LLC | 14 | $279 |
| Axsome Therapeutics, Inc. | 5 | $230 |
| Corium, LLC | 15 | $220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $181 |
| Ironshore Pharmaceuticals Inc. | 7 | $126 |
| Noven Therapeutics, LLC | 6 | $115 |
| Teva Pharmaceuticals USA, Inc. | 6 | $104 |
| Vanda Pharmaceuticals Inc. | 5 | $101 |
| Tris Pharma Inc | 6 | $100 |
| Neurocrine Biosciences, Inc. | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Collegium Pharmaceutical, Inc. | 4 | $71 |
| E.r. Squibb & Sons, L.L.C. | 3 | $67 |
| Sunovion Pharmaceuticals Inc. | 4 | $67 |
| Acadia Pharmaceuticals Inc | 2 | $39 |
| Eisai Inc. | 2 | $28 |
| Neos Therapeutics, LP | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,398 in reported general payments places this provider in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 15 | $76,317 |
| VraylarCariprazine Hcl | 22 | $37,734 |
| Duloxetine Hcl | 36 | $1,974 |
| Quetiapine Fumarate | 45 | $811 |
| Buspirone Hcl | 33 | $336 |
| Trazodone Hcl | 22 | $328 |
| Divalproex Sodium | 31 | $310 |
| Bupropion Hcl SrBupropion Hcl | 15 | $181 |
| Clonazepam | 13 | $161 |
| Benztropine Mesylate | 13 | $161 |
| Lamotrigine | 12 | $74 |
| Sertraline Hcl | 15 | $59 |
| Escitalopram Oxalate | 16 | $45 |
| Fluoxetine Hcl | 16 | $28 |
| Zolpidem Tartrate | 12 | $5 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $104 | $76,31715 claims |
| AbbVieVraylar | $1,040 | $37,73422 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Other psychiatric/mental health in Suwanee
- Bradley MosherSuwanee$13K
- Mia MisonSuwanee$12K
- Susan LangSuwanee$8K
- Candace TrippeSuwanee$5K
- Allison AndresonSuwanee$5K
- Phuong-Tuyen leSuwanee$5K
- Phyillis Kennedy-HowellBarney$673K
- Jessica OliverThomasville$233K
- Sherri KrollBrunswick$155K
- Taylor LeblancAlbany$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.